SCHEMBL23913166

SCHEMBL23913166

CC(C)(C)OC(=N)N1CCCCN1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4923319 0.78 HPGD (0.41) MMP3
SCHEMBL1654758 0.76 HPGD (0.44) MMP3
SCHEMBL2125387 0.72 USP2 (0.42)
SCHEMBL10820207 0.71 HPGD (0.41)
SCHEMBL6952529 0.70 HPGD (0.43)
SCHEMBL23913543 0.68 MMP3 (0.35) MMP3
SCHEMBL27323442 0.66 CA2 (0.44) MMP3
SCHEMBL24934499 0.66 HPGD (0.34)
SCHEMBL20197951 0.63
SCHEMBL23913236 0.63 MMP3 (0.39) MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317089-A1 HERBICIDALLY ACTIVE SUBSTITUTED PHENYLPYRIMIDINES BAYER AKTIENGESELLSCHAFT (DE) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317089-A1 HERBICIDALLY ACTIVE SUBSTITUTED PHENYLPYRIMIDINES DDT, DPYD, GSTP1 MMP3 3157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.